CD4 and infection: Our research suggests that therapeutic targeting of S1P availability early in infection via SPHK inhibition and phosphorylated SAMHD1 modulation will aid in the development of strategies to prevent establishment of initial infection and hinder cell-to-cell transmission of HIV-1 in CD4 T cells.